Clinical Trial Update: Is Augmentation of PORH by Rosuvastatin Adenosine-receptor Mediated? [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating whether rosuvastatin augments post-occlusive reactive hyperemia via adenosine-receptor mediation. The Radboud Universit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Disease

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Atherosclerosis, Cardiovascular Disease | Phase 4 | Status: COMPLETED